Trademark Overview
On Tuesday, May 5, 2026, a trademark application was filed for HEALX USA with the United States Patent and Trademark Office. The USPTO has given the HEALX USA trademark a serial number of 99804659. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, May 5, 2026. This trademark is owned by Healx USA, Inc.. The HEALX USA trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Scientific and technological services and research and design relating thereto, namely, drug discovery services using artificial intelligence; industrial analysis and research services; design and development of computer hardware and software; biological research; research and development of new products for others; pharmaceutical drug development services; drug discovery services; data and literature mining services, namely, the development of automated Natural Language Processing software; software design; computer software design; consultancy pertaining to pharmacology; consultancy pertaining to pharmaceuticals; maintaining databases pertaining to rare diseases; medical treatment for rare diseases; scientific research for medical purposes in the field of rare diseases; research and development services in the field of artificial intelligence; computer software development; computer software development for use in the healthcare field; computer software development for use in the fie...
Medical services; health consultancy; healthcare services; medical treatment services for rare diseases; healthcare advisory services; collation of information in the healthcare sector, namely, the development and collation of rare disease knowledge data sets; pharmaceutical advice; medical clinic services; medical advice for individuals with rare diseases; advisory services relating to rare diseases; advisory services relating to treatment of rare diseases; provision of medicine in the field of rare diseases, namely, developing treatments for unmet medical needs